tm logo
MYRIAMED
Live/Registered
REGISTERED

on 07 May 2024

Last Applicant/ Owned by

37079 Göttingen

DE

Serial Number

79350987 filed on 07th Apr 2022

Registration Number

7376414 registered on 07th May 2024

in the Principal Register

Correspondent Address

Michael A. Whittaker

Michael A. Whittaker Acuity Law Group

Suite E70-150

Encinitas, CA 92024

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

MYRIAMED

Scientific and industrial research in particular in the biochemical, diagnostic or pharmaceutical fields; biochemical or pharmaceutical laboratory services, in particular in the field of cultivation of cells and tissues; drug discovery services, in particular drug discovery services based on tissue engineered organ platforms; scientific and technological services and research in the field of regen Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Scientific and industrial research in particular in the biochemical, diagnostic or pharmaceutical fields; biochemical or pharmaceutical laboratory services, in particular in the field of cultivation of cells and tissues; drug discovery services, in particular drug discovery services based on tissue engineered organ platforms; scientific and technological services and research in the field of regenerative medicine; cell culture services for scientific and research purposes, for others


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [009]
Computer & Software Products & Electrical & Scientific Products


Scientific research and laboratory apparatus for drug screening or potency assays; cell culture apparatus for laboratory use, in particular cell culture plates and tissue culture plates for the generation and/or cultivation of engineered tissue


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical and veterinary preparations, in particular cells and tissues for treatment of cardiac diseases, degenerative muscular diseases, fibrotic diseases, neurodegenerative diseases, connective tissue diseases or disorders with impaired scaring and wound healing; pharmaceutical preparations for the renewal and regeneration of organs; pharmaceutical preparations for use in cellular therapy; biological tissue derived from stem cells for medical purposes; tissue-regenerative pharmaceutical preparations


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Chemicals for use in industry and science, in particular reagents for cultivation of cells and tissue; cells for research or for scientific purposes, namely, cells, in particular genetically modified cells, human cells and cells derived from induced pluripotent stem cells, in particular cardiomyocytes derived from human induced pluripotent stem cells, skeletal cells derived from human induced pluripotent stem cells, stroma cells derived from human induced pluripotent stem cells, and neuronal cells derived from human induced pluripotent stem cells; biological tissues, other than for medical or veterinary purposes, namely, tissues in particular engineered tissues, in particular tissue comprising cells derived from induced pluripotent stem cells and macroscale muscle tissue, in particular human heart muscle constructed from cardiomyocytes derived from human induced pluripotent stem cells, human skeletal muscle constructed from skeletal cells derived from human induced pluripotent stem cells, human fibrotic tissue constructed from stroma cells derived from human induced pluripotent stem cells, connective tissue constructed from connective tissue cells derived from human induced pluripotent stem cells, brain tissue derived from human induced pluripotent stem cells, and neuronal organoids; biological preparation for use in cell cultures other than for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes, namely, disease models based on engineered tissue or engineered cells


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79350987

Mark Type

No Service Mark

Attorney Docket Number

No SCH-TM-023US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
23rd Nov 2024FINAL DECISION TRANSACTION PROCESSED BY IB
31st Oct 2024FINAL DISPOSITION NOTICE SENT TO IB
30th Oct 2024FINAL DISPOSITION PROCESSED
07th Aug 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07th May 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
07th May 2024REGISTERED-PRINCIPAL REGISTER
25th Mar 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06th Mar 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06th Mar 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04th Mar 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED